Frontiers | Diabetic cardiomyopathy: Clinical phenotype and practice
Molecules | Free Full-Text | Progress in Metabonomics of Type 2 Diabetes Mellitus
Proteomic pathways to metabolic disease and type 2 diabetes in the pancreatic islet - ScienceDirect
Cells | Free Full-Text | MicroRNA Signatures as Future Biomarkers for Diagnosis of Diabetes States
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | SpringerLink
Temporal metabolic and transcriptomic characteristics crossing islets and liver reveal dynamic pathophysiology in diet-induced diabetes - ScienceDirect
Lentivirus Mediated Pancreatic Beta-Cell-Specific Insulin Gene Therapy for STZ-Induced Diabetes: Molecular Therapy
Human Islet Expression Levels of Prostaglandin E2 Synthetic Enzymes, But Not Prostaglandin EP3 Receptor, Are Positively Correlated with Markers of β-Cell Function and Mass in Nondiabetic Obesity | ACS Pharmacology & Translational
Pancreatic β Cell Dedifferentiation as a Mechanism of Diabetic β Cell Failure: Cell
Frontiers | Potential Novel Serum Metabolic Markers Associated With Progression of Prediabetes to Overt Diabetes in a Chinese Population
IJMS | Free Full-Text | Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes
Identification of potential markers for type 2 diabetes mellitus via bioinformatics analysis
A Map of Human Type 1 Diabetes Progression by Imaging Mass Cytometry - ScienceDirect
Strategies for durable β cell replacement in type 1 diabetes | Science
IJMS | Free Full-Text | Stem Cell-Derived Islets for Type 2 Diabetes
LRH-1 agonism favours an immune-islet dialogue which protects against diabetes mellitus | Nature Communications
Metabolic and proteomic signatures of type 2 diabetes subtypes in an Arab population | Nature Communications
Endocrines | Free Full-Text | Diabetic Ketoacidosis Management: Updates and Challenges for Specific Patient Population
Endocrine and Metabolic Insights from Pancreatic Surgery: Trends in Endocrinology & Metabolism
Frontiers | Therapeutic Strategies for Diabetes: Immune Modulation in Pancreatic β Cells
Understanding multifactorial brain changes in type 2 diabetes: a biomarker perspective - The Lancet Neurology
Targeting inflammation in the treatment of type 2 diabetes: time to start | Nature Reviews Drug Discovery
Acceleration of β Cell Aging Determines Diabetes and Senolysis Improves Disease Outcomes - ScienceDirect
